NCT06774690Recruiting
Intra Artherial Therapies in Treatment of Primary Liver Diseases: an Observational Study
Source: ClinicalTrials.gov · Last updated 14 Jan 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The goal of this observational study is to learn what are the best conditions that will give a positive outcome to men and women that receive a intra arterial therapy (IAT) for primary liver cancer. Intra arterial therapies are radiologic procedures that block liver cancer blood supply. The researchers will collect the data of participants located in the Radiology department in "IRCCS Azienda Ospedaliera Universitaria" Hospital in Bologna and will study clinic and radiological traits to understand which is the best case scenario for a optimal treatment response.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 3300 (estimated)
- First submitted
- 9 Jan 2025
- Start date
- 21 Apr 2021
- Primary completion date
- Mar 2030
- Lead sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Diseases
- Liver and biliary tract cancer
- NCT number
- NCT06774690
What you commit to
- Study type: Observational
- Planned participants: 3300
- From 21 Apr 2021 to the primary completion date, Mar 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- liver failure
Other
- shunt of gastro intestinal arteries that cannot be embolized
- metastasis spread outside of the liver
Who the study is looking for
- diagnosis of Hepatocellular carcinoma (HCC) or intrahepatic cholangiocarcinoma (iCCA) and clinical indication to receive or have already received one of the following treatments:
- Trans-arterial embolization (TAE),
- Transarterial chemoembolization (TACE),
- Transarterial radioembolization (TARE)
- Drug-eluting beads chemoembolization (DEB-TACE)
- Age over 18
- To give informed consent
Age in the registry: 18 years to - · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| IRCCS Azienda Ospedaliero-Universitaria di Bologna Coordinator of this site? Confirm its status | Bologna | Italy | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.